Immunovaccine Inc is going to be the solution to End Cancer?

Immunotherapy is going to be the solution to put an end to cancer.  We have discovered a new way to deliver messages to immune system. We are co-devel …

Solution to End Cancer

© 2020 www.B-TV.com. All Rights Reserved.

Immunotherapy is going to be the solution to put an end to cancer. We have discovered a new way to deliver messages to immune system. We are co-developing our products with two partners, Merck and Insight. It has the potential to transform the way we work with our immune system.We believe that the key to leveraging the power of human immunity resides in the way we communicate with our immune system. Modern medicine has created access to technologically advanced targets. Proteins, peptides, DNA/RNA vaccines—that can be used to encode directives to our immune system. But those commands are secondary, as our immune systems have already evolved over millions of years to precisely and powerfully recognize and respond to a wide variety of danger signals.For more information on Immunovaccine Inc (IMV.TO) please fill out the form.

No items found.

You might also like

Harvest HHII: How Can Investors Combine International Growth With Monthly Income?
ETFs
July 28, 2026

Harvest HHII: How Can Investors Combine International Growth With Monthly Income?

This is some text inside of a div block.
Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?
Finance
July 23, 2026

Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?

This is some text inside of a div block.
Brompton Funds
ETFs
July 23, 2026

Brompton Funds: Enhanced Multi-Asset Income ETF - BMAX

BMAX is designed to provide attractive monthly distributions and the opportunity for capital appreciation by investing in a portfolio of Brompton ETFs and preferred shares.

This is some text inside of a div block.
Subscribe and receive the investor Info